SINGAPORE: The updated JN.1 Novavax/Nuvaxovid COVID-19 vaccine will be offered under the national vaccination programme at ...

Novavax (NVAX) closed at $9.34 in the latest trading session, marking a +1.3% move from the prior day. The average of price targets set by Wall Street analysts indicates a potential upside of 81.6 ...

Importantly, this deal allows Novavax to shed ~$80 million in annual operating costs. The sale closed as scheduled on 12/30/2024. Its latest 10 ... finish line to FDA approval, deprives it of ...

Novavax (NVAX) closed at $9.34 in the latest trading session ... Novavax is working with the FDA to explore a pathway for accelerated approval of the COVID-19-flu combination and standalone flu ...

These awards were approved ... to use the latest selected strain and the guidance from the U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA) and World Heal Novavax, Inc ...

Recently, Zacks.com users have been paying close attention to Novavax (NVAX). This makes it worthwhile to examine what the stock has in store. Novavax (NVAX) witnessed a jump in share price last ...

German news agency DPA reported on Wednesday. Lufthansa is set to buy 41 percent of ITA – the successor to bankrupt Alitalia – for €325 million. The European Commission gave final approval to ...

German carrier Lufthansa is set to acquire a stake in Italian state-owned airline ITA Airways on Monday, bringing years of negotiations over a merger to a close, news agency Ansa reported ... faced a ...